Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Gabrielle Meyers; Mehdi Hamadani; Michael Martens; Haris Ali; Patrice Chevallier; Hannah Choe; Andrew C. Harris; Ernst Holler; Eric van Hooren; Willem Klaassen; Eric Leifer; Ypke van Oosterhout; Lia Perez; Iskra Pusic; Matthias Stelljes; Walter van der Velden; Emanuele Ammatuna; David Beauvais; Jérôme Cornillon; Richard T. Maziarz; Johannes Schetelig; Jennifer Romeril; Margaret L. MacMillan; John E. Levine; Gérard Socié

doi:10.1038/s41409-023-02110-4

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Gabrielle Meyers, Mehdi Hamadani, Michael Martens, Haris Ali, Patrice Chevallier, Hannah Choe, Andrew C. Harris, Ernst Holler, Eric van Hooren, Willem Klaassen, Eric Leifer, Ypke van Oosterhout, Lia Perez, Iskra Pusic, Matthias Stelljes, Walter van der Velden, Emanuele Ammatuna, David Beauvais, Jérôme Cornillon, Richard T. MaziarzJohannes Schetelig, Jennifer Romeril, Margaret L. MacMillan, John E. Levine, Gérard Socié

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	1416-1418
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	58
Issue number	12
DOIs	https://doi.org/10.1038/s41409-023-02110-4
State	Published - Dec 2023

Access to Document

10.1038/s41409-023-02110-4

Cite this

Meyers, G., Hamadani, M., Martens, M., Ali, H., Chevallier, P., Choe, H., Harris, A. C., Holler, E., van Hooren, E., Klaassen, W., Leifer, E., van Oosterhout, Y., Perez, L., Pusic, I., Stelljes, M., van der Velden, W., Ammatuna, E., Beauvais, D., Cornillon, J., ... Socié, G. (2023). Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002. Bone Marrow Transplantation, 58(12), 1416-1418. https://doi.org/10.1038/s41409-023-02110-4

@article{00ce9ed14cf74527b7a5fa6722344f5d,

title = "Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002",

author = "Gabrielle Meyers and Mehdi Hamadani and Michael Martens and Haris Ali and Patrice Chevallier and Hannah Choe and Harris, {Andrew C.} and Ernst Holler and {van Hooren}, Eric and Willem Klaassen and Eric Leifer and {van Oosterhout}, Ypke and Lia Perez and Iskra Pusic and Matthias Stelljes and {van der Velden}, Walter and Emanuele Ammatuna and David Beauvais and J{\'e}r{\^o}me Cornillon and Maziarz, {Richard T.} and Johannes Schetelig and Jennifer Romeril and MacMillan, {Margaret L.} and Levine, {John E.} and G{\'e}rard Soci{\'e}",

note = "Funding Information: Support for this study was provided by grants U10HL069294 and U24HL138660 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute along with contributions by Xenikos BV. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ",

year = "2023",

month = dec,

doi = "10.1038/s41409-023-02110-4",

language = "English",

volume = "58",

pages = "1416--1418",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

number = "12",

}

Meyers, G, Hamadani, M, Martens, M, Ali, H, Chevallier, P, Choe, H, Harris, AC, Holler, E, van Hooren, E, Klaassen, W, Leifer, E, van Oosterhout, Y, Perez, L, Pusic, I, Stelljes, M, van der Velden, W, Ammatuna, E, Beauvais, D, Cornillon, J, Maziarz, RT, Schetelig, J, Romeril, J, MacMillan, ML, Levine, JE & Socié, G 2023, 'Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002', Bone Marrow Transplantation, vol. 58, no. 12, pp. 1416-1418. https://doi.org/10.1038/s41409-023-02110-4

TY - JOUR

T1 - Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD

T2 - final report of BMT CTN 2002

AU - Meyers, Gabrielle

AU - Hamadani, Mehdi

AU - Martens, Michael

AU - Ali, Haris

AU - Chevallier, Patrice

AU - Choe, Hannah

AU - Harris, Andrew C.

AU - Holler, Ernst

AU - van Hooren, Eric

AU - Klaassen, Willem

AU - Leifer, Eric

AU - van Oosterhout, Ypke

AU - Perez, Lia

AU - Pusic, Iskra

AU - Stelljes, Matthias

AU - van der Velden, Walter

AU - Ammatuna, Emanuele

AU - Beauvais, David

AU - Cornillon, Jérôme

AU - Maziarz, Richard T.

AU - Schetelig, Johannes

AU - Romeril, Jennifer

AU - MacMillan, Margaret L.

AU - Levine, John E.

AU - Socié, Gérard

N1 - Funding Information: Support for this study was provided by grants U10HL069294 and U24HL138660 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute along with contributions by Xenikos BV. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85172133108&partnerID=8YFLogxK

U2 - 10.1038/s41409-023-02110-4

DO - 10.1038/s41409-023-02110-4

M3 - Letter

C2 - 37749187

AN - SCOPUS:85172133108

SN - 0268-3369

VL - 58

SP - 1416

EP - 1418

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 12

ER -

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Access to Document

Other files and links

Cite this